Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online September 7, 2006
Stem Cells Vol. 25 No. 1 January 2007, pp. 181 -188
doi:10.1634/stemcells.2006-0371; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0371v1
25/1/181    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haupt, S.
Right arrow Articles by Brüstle, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haupt, S.
Right arrow Articles by Brüstle, O.

STEM CELL GENETICS AND GENOMICS

Stage-Specific Conditional Mutagenesis in Mouse Embryonic Stem Cell-Derived Neural Cells and Postmitotic Neurons by Direct Delivery of Biologically Active Cre Recombinase

Simone Haupta,b, Frank Edenhofera,b, Michael Peitza,b, Anke Leinhaasa, Oliver Brüstlea

aInstitute of Reconstructive Neurobiology and
bStem Cell Engineering Group, Life & Brain Center and Hertie Foundation, University of Bonn, Bonn, Germany

Key Words. Site-specific recombination • Neural differentiation • Protein transduction • Neural repair • Stem cell therapy Conditional mutagenesis

Correspondence: Frank Edenhofer, Ph.D., Stem Cell Engineering Group, Institute of Reconstructive Neurobiology, Life & Brain Center, University of Bonn and Hertie Foundation, Sigmund-Freud Strasse 25, 53105 Bonn, Germany. Telephone: 49-228-6885-529; Fax: 49-228-6885-531; e-mail: f.edenhofer{at}uni-bonn.de

Received on June 19, 2006; accepted for publication on August 31, 2006.

First published online in STEM CELLS EXPRESS  September 7, 2006.


Conditional mutagenesis using Cre/loxP recombination is a powerful tool to investigate genes involved in neural development and function. However, the efficient delivery of biologically active Cre recombinase to neural cells, particularly to postmitotic neurons, represents a limiting factor. In this study, we devised a protocol enabling highly efficient conditional mutagenesis in ESC-derived neural progeny. Using a stepwise in vitro differentiation paradigm, we demonstrate that recombinant cell-permeable Cre protein can be used to efficiently induce recombination at defined stages of neural differentiation. Recombination rates of more than 90% were achieved in multipotent pan-neural and glial precursors derived from the Z/EG reporter mouse ESC line, in which Cre recombination activates enhanced green fluorescent proteinexpression. Recombined precursor cells displayed a normal phenotype and were able to differentiate into neurons and/or glial cells, indicating that Cre treatment has no overt side effects on proliferation and neural differentiation. Our data further demonstrate that recombination via Cre protein transduction is not restricted to dividing cells but can even be applied to postmitotic neurons. The ability to conduct Cre/loxP recombination at defined stages of stem cell differentiation in an expression-independent manner provides new prospects for studying the role of individual genes under stringent temporal control.




This article has been cited by other articles:


Home page
Stem CellsHome page
T. C. Dinger, S. Eckardt, S. W. Choi, G. Camarero, S. Kurosaka, V. Hornich, K. J. McLaughlin, and A. M. Muller
Androgenetic Embryonic Stem Cells Form Neural Progenitor Cells In Vivo and In Vitro
Stem Cells, June 1, 2008; 26(6): 1474 - 1483.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.